The prognostic impact of p53 expression in MDS was recently studied [84,85,86]; its overexpression is associated with a more aggressive clinical outcome and adverse histological prognostic factors, such as BM fibrosis [86,87]. Here, TP53 is linked to myelodysplastic syndrome.